Are the "ounce-equivalents" in the Protein Foods Groups Really Equivalent?

NCT ID: NCT03142737

Last Updated: 2024-09-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

45 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-05-08

Study Completion Date

2019-05-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators will determine effects of different sources of protein on whole-body net protein synthesis and muscle protein synthesis in young healthy participants.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Over the past 35 years the United States Department of Agriculture (USDA) Dietary Guidelines for Americans (DGAs) has sought to translate recommendations on nutrient requirements (i.e., Recommended Dietary Allowances (RDAs) from the Food and Nutrition Board of the Institute of Medicine (IOM) into practical nutritional advice for the American public. Over the same time interval in which the Dietary Guidelines have existed the occurrence of nutrition-related health problems in the United States has escalated dramatically, showing that the population of obesity in U.S. has reached to a total of 35.8%. In addition, the lack of appropriate focus on protein nutrition is a major shortcoming of the DGAs. Not only is the amount of protein not a major focus, but also absolutely no mention is made of protein quality. Protein quality refers to the amount, profile, and true ileal digestibility of the essential amino acids (EAAs) in the protein. However, the concept of protein quality is not new, as the Protein Digestible Corrected Amino Acid Score was published by the Food and Agriculture Organization of the World Health Organization in 1993. Although animal protein (and beef specifically) has much higher the Digestible Indispensable Amino Acid Score (DIAAS) than plant proteins, often by as much as two fold, DIAAS has not taken account of the importance of the amount and profile of EAAs in individuals proteins. Moreover, the misrepresentation of the equivalencies of various food sources of protein in MyPlate raises the question of the process by which this occurred, and how can the process be influenced to more accurately reflect that high quality of animal proteins, including beef? Therefore, we propose to make these measurements in response to intake of "equivalent "(according to MyPlate) amounts of beef, kidney beans, eggs and peanut butter. Demonstration that the functional responses to these varied sources of protein coincide with the predictions from the USDA nutrient data base and calculation of the DIAAS will provide needed support to redefine "ounce equivalents" of protein food sources according to those data bases for all animal and plant sources of protein.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Protein Metabolism

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Red kidney bean intake

Subjects will consume 1/2 cup of cooked red kidney bean following diet normalization for 3 days.

Group Type EXPERIMENTAL

Red kidney bean intake

Intervention Type OTHER

Each participant will consume 1/2 cup of cooked red kidney bean

Eggs intake

Subjects will consume 2 cooked large eggs following diet normalization for 3 days.

Group Type EXPERIMENTAL

Eggs intake

Intervention Type OTHER

Each participant will consume 2 cooked large eggs.

Peanut butter intake

Subjects will consume 2 tablespoons of peanut butter following diet normalization for 3 days.

Group Type EXPERIMENTAL

Peanut butter intake

Intervention Type OTHER

Each participant will consume 2 tablespoons of peanut butter.

Ground beef intake

Subjects will consume 2 ounces of 90% lean ground beef following diet normalization for 3 days.

Group Type EXPERIMENTAL

Ground beef intake

Intervention Type OTHER

Each participant will consume 2 ounces of 90% lean ground beef.

Intact beef intake

Subjects will consume 2 ounces of intact beef following diet normalization for 3 days.

Group Type EXPERIMENTAL

Intact beef intake

Intervention Type OTHER

Each participant will consume 2 ounces of intact beef.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Red kidney bean intake

Each participant will consume 1/2 cup of cooked red kidney bean

Intervention Type OTHER

Eggs intake

Each participant will consume 2 cooked large eggs.

Intervention Type OTHER

Peanut butter intake

Each participant will consume 2 tablespoons of peanut butter.

Intervention Type OTHER

Ground beef intake

Each participant will consume 2 ounces of 90% lean ground beef.

Intervention Type OTHER

Intact beef intake

Each participant will consume 2 ounces of intact beef.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women, ages 20-40 years
* BMI from 20 to 29.9 kg/m2

Exclusion Criteria

* Current diagnosis of diabetes
* History of malignancy in the 6 months prior to enrollment
* History of gastrointestinal bypass surgery
* History of a chronic inflammatory condition or other chronic diseases (Lupus, HIV/AIDS, etc)
* Female subjects who are currently pregnant
* Subjects who are unable to eat animal protein
* Subjects who are unable to stop eating protein or Amino Acid (AA) supplements during the participation
* Subjects who report regular resistance training (more than twice per week)
* Subjects who have concomitant use of corticosteroids (ingestion, injection or transdermal)
* Hemoglobin less than 9.5 g/dL at the screening visit
* Platelets less than 250,000 at the screening visit.
* Any other disease or condition that would place the subject at increased risk of harm if they were to participate, at the discretion of the study physician
Minimum Eligible Age

20 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Arkansas

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Robert Wolfe, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Arkansas

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

205366

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.